A detailed history of Deutsche Bank Ag\ transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,234,697 shares of STVN stock, worth $22.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,234,697
Previous 188,398 555.37%
Holding current value
$22.6 Million
Previous $5.14 Million 670.92%
% of portfolio
0.02%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.34 - $34.28 $26.5 Million - $35.9 Million
1,046,299 Added 555.37%
1,234,697 $39.6 Million
Q4 2023

Feb 14, 2024

BUY
$25.21 - $34.66 $2.41 Million - $3.31 Million
95,523 Added 102.85%
188,398 $5.14 Million
Q3 2023

Nov 09, 2023

SELL
$26.91 - $35.49 $2.28 Million - $3.01 Million
-84,815 Reduced 47.73%
92,875 $2.76 Million
Q2 2023

Aug 14, 2023

SELL
$25.15 - $32.86 $1.43 Million - $1.87 Million
-56,856 Reduced 24.24%
177,690 $5.75 Million
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $714,385 - $1.06 Million
-40,822 Reduced 14.82%
234,546 $6.07 Million
Q4 2022

Feb 13, 2023

BUY
$13.95 - $19.28 $378,575 - $523,220
27,138 Added 10.93%
275,368 $4.95 Million
Q3 2022

Nov 14, 2022

SELL
$14.66 - $18.3 $758,200 - $946,457
-51,719 Reduced 17.24%
248,230 $4.21 Million
Q2 2022

Aug 11, 2022

SELL
$14.1 - $20.26 $181,438 - $260,705
-12,868 Reduced 4.11%
299,949 $4.74 Million
Q1 2022

May 13, 2022

BUY
$15.23 - $21.47 $909,809 - $1.28 Million
59,738 Added 23.6%
312,817 $6.29 Million
Q4 2021

Feb 11, 2022

SELL
$21.65 - $27.0 $450,947 - $562,383
-20,829 Reduced 7.6%
253,079 $5.68 Million
Q3 2021

Nov 04, 2021

BUY
$19.51 - $28.7 $5.34 Million - $7.86 Million
273,908 New
273,908 $6.93 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $4.85B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.